Genetic Architecture of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Conditions: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Interventions: Genetic: Genome-wide association study Sponsors: Istituto Clinico Humanitas Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Genetic Architecture of CIDP
Conditions: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Interventions: Genetic: Genome-wide association study Sponsors: Istituto Clinico Humanitas Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Rituximab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Conditions: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Interventions: Drug: Rituximab Sponsors: Istituto Clinico Humanitas; IRCCS National Neurological Institute " C. Mondino " Foundation Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Conditions: Chronic Inflammatory Demyelinating Polyneuropathy Interventions: Drug: riliprubart; Drug: Placebo; Drug: riliprubart; Drug: Placebo; Drug: IVIg; Drug: Placebo; Drug: IVIg premedication Sponsors: Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
Conditions: Chronic Inflammatory Demyelinating Polyradiculoneuropathy; Polyneuropathy, Inflammatory Demyelinating, Chronic Interventions: Drug: Riliprubart; Drug: Placebo; Drug: Riliprubart; Drug: Placebo Sponsors: Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.
Conditions: Chronic Inflammatory Demyelinating Polyneuropathy Interventions: Device: Actimyo Sponsors: Dr. St éphanie Delstanche; Sysnav; Centre Hospitalier Universitaire de Liege Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2023 Category: Research Source Type: clinical trials
Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
Conditions: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP); Vasculitic Neuropathy; POEMS Syndrome; Multifocal Motor Neuropathy; Charcot-Marie-Tooth; hATTR Amyloidosis; Diabetic Polyneuropathy; Idiopathic Neuropathy; Polyneuropathies Interventions: Other: Validity and reliability of outcome measures in polyneuropathy; Other: Healthy controls Sponsor: Rigshospitalet, Denmark Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials
